April 17th 2019
A few weeks ago, I expressed surprise that research on sphingosine-1-phosphate covered a span of 50 years. This now pales into insignificance with a new publication (Montinari, M.R. et al. The first 3500 years of aspirin history from its roots - A concise summary. Vasc. Pharm., 113, 1-8 (2019); DOI). Of course there were no Proceedings of the Sumerian (or Egyptian) Academy of Sciences back then, but the Ebers Papyrus (1534BCE) apparently reports the use of willow bark as a painkiller and antipyretic. A mere 1000 years later, Hippocrates was aware of the medicinal properties of this plant family, but the true science of the salicylates began in the late 1700s. As the review recounts, we now know, thanks to the work of Sir John Vane and colleagues, that the mechanism of action of aspirin and other non-steroidal anti-inflammatory drugs is the dose-dependent inhibition of prostaglandin biosynthesis via its action upon cyclooxygenases. Why not put your feet up and read it during your next coffee break - at least it is a change from Brexit?
The effects of the Ebola virus on the lipid metabolism of patients with the disease was also mentioned in an earlier blog. Now a new review describes how this virus (and others) is able to take phosphatidylserine from the inner layer of the host plasma membrane and externalize it on the viral envelope to exploit the host apoptotic clearance machinery to enhance their entry into host cells (Nanbo, A. and Kawaoka, Y. Molecular mechanism of externalization of phosphatidylserine on the surface of Ebola virus particles. DNA Cell Biol., 38, 115-120 (2019); DOI - open access).
There is currently great interest in oxidized phospholipids in animals, because of their influence on innumerable disease states. However, they are just as important in plants, in which both galactolipids and phospholipids are known to contain specific oxylipins, thanks largely to the marvels of modern mass spectrometry. The best known of these are the arabidopsides, which are formed in leaves upon wounding, but also in distant unstressed leaves so there must be some means of communication between them. A new review summarizes current knowledge (Genva, M. et al. New insights into the biosynthesis of esterified oxylipins and their involvement in plant defense and developmental mechanisms. Phytochem. Rev., 18, 343-358 (2019); DOI.).
April 10th 2019
There have been any number of excellent review articles on the topic of lipidomics in recent years that together cover most aspects of the techniques involved in some depth. However, if you are a complete novice to the subject where would you start? I can recommend a new review from the laboratory of Prof. Xianlin Han (Wang, J. et al. Tutorial on lipidomics. Anal. Chim. Acta, 1061, 28-41 (2019); DOI). The text of the paper is simple, straight-forward and readable, and anything missing is covered by an extensive list of references.
This has been a good week for papers dealing with lipid methodology, and I suspect that one on the topic of oxylipins will prove to be seminal (Watrous, J.D. et al. Directed non-targeted mass spectrometry and chemical networking for discovery of eicosanoids and related oxylipins. Cell Chem. Biol., 26, 433-442 (2019); DOI). I have yet to get hold of a copy, but from the abstract it appears that there are many more lipid mediators of this type in human plasma than have been adequately characterized to date. The authors are surely having fun exploring the chemistry of these now, especially to determine which are primary metabolites, with studies of the biological properties to follow. "Fun" is probably not the correct word, as I know how frustrating it can be to try to obtain the structures of fatty acid derivatives from minute amounts of material.
In addition, I was intrigued by a paper on derivatization reactions in the solid phase (Atapattu, S.N. and Rosenfeld, J.M. Micro scale analytical derivatizations on solid phase. Trends Anal. Chem., 113, 351-356 (2019); DOI). There do not yet appear to be many applications to main-stream lipids as yet, but the potential is there. The same journal issue has two further reviews dealing with solid-phase methods for preparing lipid extracts.
The journal Biochimie has a special issue (Volume 159, Pages 1-122, April 2019) devoted to the topic of "Fatty acids and lipopolysaccharides from health to disease" edited by Michel Narce and Isabelle Niot. An eclectic range of topics is covered within the main subject areas.
April 3rd 2019
It is almost 100 years since the discovery of vitamin E or tocopherol so it is appropriate to see a special journal issue devoted to review articles on the topic - "Vitamin E - Regulatory Roles" edited by A. Azzi and W.J. Whelan (IUBMB Life, Volume 71, Issue 4, Pages: 401-522, April 2019). In the early years, the function of tocopherol as an antioxidant was the focus of most research, then the signalling roles came to the fore, and now there are multiple avenues that are being explored. It seems that I am going to be rather busy now with updates to my tocopherol page, as even a cursory glance at the abstracts shows there is much that I have missed in the last year or two. In particular, I suspect that reading up on the biochemistry of the tocopherol metabolites is going to be a considerable task. For example, I was not aware until now of a publication describing how these interact with 5-lipoxygenase and thence interfere with leukotriene signalling (Pein, H. and 30 others. Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase. Nat. Commun., 9, 3834 (2018); DOI).
However, another important review is demanding my attention at the moment, and this requires updates to several of my web pages - two already (O''Donnell, V.B. et al. Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death. Sci. Signal., 12, eaau2293 (2019); DOI - open access). Amongst much of interest, it is suggested that the biosynthetic enzymes for free hydroxyeicosatetraenoic acids and their esterified products are colocalized and work cooperatively to the same time scale when cells are activated.
March 27th 2019
I had thought that sphingosine-1-phosphate biochemistry was largely a product of this century, so I was surprised to see the title of a new review (Saba, J.D. Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease. J. Lipid Res., 60, 456-463 (2019); DOI). However, it appears that the first work on this key enzyme of sphingolipid catabolism was published by Wilhelm Stoffel (who recently celebrated his 90th birthday) and colleagues in 1969. This work seems to have been ahead of its time and was largely forgotten until the late 1990s, when research was stimulated by the new findings on the biological activities of this lipid. Stoffel was also of course the key pioneer in the revealing the mechanism for the biosynthesis of sphingoid bases (see - Stoffel, W. Studies on the biosynthesis and degradation of sphingosine bases. Chem. Phys. Lipids, 5, 139-158 (1970); DOI). Scientific historians may correct me, but I suspect that it was a further 20 years until the next important paper on the topic was published from Sarah Spiegel's laboratory (Zhang, H. et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol., 114, 155-167 (1991); DOI).
Nature can confound the best lipid classification schemes. For example, is the lipid illustrated (phosphatidylmonogalactosyldiacylglycerol) a glycolipid, a phospholipid, a glycophospholipid or a phosphoglycolipid (there is a difference between the last two as described herehttp://www.lipidhome.co.uk)? In essence, it is a monogalactosyldiacylglycerol linked by a phosphate bond to phosphatidic acid. It was first described from a bacterium some years ago, and there are glucosyl equivalents, but a new paper describes undoubtedly the best characterization, including the β-D-galactopyranosyl unit and polyunsaturated acyl groups, together with its biological properties (Manzo, E. et al. Immunostimulatory phosphatidylmonogalactosyldiacylglycerols (PGDG) from the marine diatom Thalassiosira weissflogii: inspiration for a novel synthetic toll-like receptor 4 agonist. Marine Drugs, 17, 103 (2019); DOI). It is probably best considered as a phosphoglycolipid, as it is believed to be derived biosynthetically from monogalactosyldiacylglycerols by a transphosphatidylation reaction with phosphatidylglycerol.
Two weeks ago, I suggested that a review of the connections between glycerolipid and sphingolipid biochemistry might be timely. My apologies but I have been reminded that one exists and is well worth reading (Rodriguez-Cuenca, S. et al. Sphingolipids and glycerophospholipids - The "ying and yang" of lipotoxicity in metabolic diseases. Prog. Lipid Res., 66, 14-29 (2017); DOI).
March 20th 2019
There have been two substantial multi-author reviews in the last six months on the health value of plant sterols and stanols in the diet (Jones, P.J.H. and 24 others. Progress and perspectives in plant sterol and plant stanol research. Nutr. Rev., 76, 725-746 (2018); DOI. Plat, J. and 19 others. Plant-based sterols and stanols in health and disease: 'Consequences of human development in a plant-based environment?' Prog. Lipid Res., 74, 87-102 (2019); DOI - the latter is open access). Both support the claims for the cholesterol lowering effects of such supplements, although there is as yet no direct evidence that there is an actual reduction in the risk of heart disease. Time only will tell, but my fingers are crossed that this does indeed work, as I have been encouraging my wife to consume one of the proprietary brands for some years. The other important information that I took from the reviews is that there may be many further benefits, and I quote from the second of these publications - "ranging from its presence and function intrauterine and in breast milk towards a potential role in the development of non-alcoholic steatohepatitis, cardiovascular disease, inflammatory bowel diseases and allergic asthma." The authors consider that these additional beneficial properties may even prove to be more important than the effects upon cholesterol lowering in the long term.
Lipidomics studies are contributing substantially to our knowledge of the metabolic consequences of diseases states, including heart disease and cancer of course where lipids play an active part. It is perhaps more surprising that this can also be true of viral diseases, and a new study describes the changes in lipids brought about by the Ebola virus (Kyle, J.E. et al. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease. PNAS, 116, 3919-3928 (2019); DOI). It appears that the plasma lipidomes are profoundly altered in survivors and fatalities, and are related to the outcome and stage of the disease and recovery. Impo
March 13, 2019
A new review publication on sphingolipids is worth reading for a number of reasons, but I was intrigued by some fascinating data on how research on these lipids has expanded in recent years (Sahu, S.K. et al. Emergence of membrane sphingolipids as a potential therapeutic target. Biochimie, 158, 257-264 (2019); DOI). The authors point out that in relation to sphingolipid metabolism their "extensive literature survey reveals a whopping 28-fold increase in the number of publications from the year 1999 onwards in comparison to papers from 1987 to 1998". I guess this has been fueled in part by the discovery of the signalling roles of lipids such as the ceramides and sphingosine-1-phosphate and in part by the development of new mass spectrometric methodologies, which have greatly simplified analysis.
It is not hard to understand why glycerolipid biochemistry and sphingolipid biochemistry are usually treated as separate subjects within lipid science. A few years ago, I was asked at a symposium whether I knew of any links between the two, and while I recalled the fact that phosphatidylcholine was an immediate precursor of sphingomyelin, my mind was a blank on other links. When I had time later, others did indeed come to mind and I began a list of additional connections, which I later incorporated into my introductory web page on sphingolipids. I continue to add to this and the most recent example is the generation of 1-O-acylceramides in skin and lipid droplets by the action of diacylglycerol acyltransferase 2 (DGAT2), a key enzyme in triacylglycerol biosynthesis. There must be more such links of which I am unaware, and I would be delighted to learn of further examples. As an alternative to my musings, perhaps someone (not me) could consider publishing a proper review on the topic!
March 6th 2019
At first glance, the topic of prostaglandins in insects may not appear to be of special interest, but a new review has some fascinating information (Stanley, D. and Kim, Y. Prostaglandins and other eicosanoids in insects: biosynthesis and biological actions. Front. Physiol., 9, 1927 (2019); DOI - open access). For example, it appears that there is very little arachidonic acid in insects, so the first step in prostaglandin synthesis seems to be release of linoleate from phospholipids by the action of phospholipase A2 for conversion to arachidonic acid. Then, insects do not possess cyclooxygenases but instead have a specific peroxidase termed 'peroxinectin', which produces PGH2. This is acted upon in turn by a PGE2 synthase. Thereafter, prostaglandins appear to have a similar innumerable range of functions in insects as in vertebrates, including hormone actions in the fat body and effects upon reproduction, fluid secretion, and the immune response.
I gather that it is easily possible to spend seven figure sums to purchase an NMR spectrometer these days, but I am intrigued by the possibilities for the use of low-cost bench-top instruments that do not require the use of cryogens in lipid analysis. I understand that they are relatively low field, up to about 80 Mhz, but early in my career 60Mhz was considered state of the art. These thoughts were stimulated by a paper on the analysis of phospholipids using 31P NMR with an instrument of this type (Gouilleux, B. et al. Analytical evaluation of low-field 31P NMR spectroscopy for lipid analysis. Anal. Chem., 91, 3035-3042 (2019); DOI - open access). The results appear to show sufficient accuracy for many routine applications in food or clinical science, and certainly at least as good as alternative low-tech methods, such as thin-layer chromatography, while being much less labour intensive. I would love to drive a Ferrari, but I am content in general with my Ford Fiesta - perhaps it might be the same with NMR spectrometers?
My current moan concerning scientific publications is poor paragraph construction. I recently came across a review article in which a single paragraph extended over three pages.
February 27th 2019
Having mentioned the need for good titles and abstracts in scientific publications in recent weeks, I should say something about the contents. I have been rather impressed by the use of colour and art work in some recent papers. When my grand-daughter was 5-6 years old, she asked me "what was life like in the black and white days?" - obviously under the impression from TV viewing that colour was a late 20th century invention. Colour in the world at large is one thing, but the world of scientific publication and presentation was largely monochromatic until well into my scientific career, although we may now take the use of colour for granted. That said, I must commend the authors of a review that has just been published for an outstanding example of the tasteful use of colour coupled with real artistic skill to complement the text and illustrate complex biological processes (Olzmann, J.A. and Carvalho, P. Dynamics and functions of lipid droplets. Nature Rev. Mol. Cell Biol., 20, 137-155 (2019); DOI).
From time to time in this blog, I have mentioned the N-acylhomoserine lactones, which govern how many bacterial species interact with each other and with their environment. A new molecular species has just been isolated with the main fatty acid component being 2E,5Z-dodecadienoic acid. Locating double bonds close to the carboxyl group can be tricky, as they have a tendency to migrate under mild reaction conditions, so the authors had to synthesise various possibilities for comparison purposes (Ziesche, L. et al. An unprecedented medium-chain diunsaturated N-acylhomoserine lactone from marine Roseobacter group bacteria. Marine Drugs, 17, 20 (2019); DOI). The references cited lead me to a publication that I had missed when it first appeared and contains an excellent review of the topic. It also introduced me to a whole new area (to me at least) of fatty acid biochemistry (Schulz, S. and Hötling, S. The use of the lactone motif in chemical communication. Nat. Prod. Rep., 32, 1042-1066 (2015); DOI - open access).
February 20th 2019
There is a new record for the most highly unsaturated natural fatty acid from a conventional source, i.e. tetratriacontadecaenoic acid or 34:10, from a fish oil supplement (Ozaki, H. et al. Basic eluent for rapid and comprehensive analysis of fatty acid isomers using reversed-phase high performance liquid chromatography/Fourier transform mass spectrometry. J. Chromatogr. A, 1585, 113-120 (2019); DOI). The methodology used does not permit detailed determination of the structure, but that illustrated appears to be the most probable. The previous record for a normal tissue belonged to 28:8(n-3) from marine dinoflagellates, although fatty acids with an even higher degree of unsaturation have been isolated from the brains of patients with genetic impairments of peroxisome function.
It has long been known that aspirin inhibits the cyclooxygenase (COX) enzymes by transferring its acetyl group irreversibly to a specific serine residue, which then protrudes into the active site and obstructs the binding of arachidonate. However, COX-2 is not completely inhibited but there is shift in reaction specificity, converting the enzyme activity from that of a cyclooxygenase to a lipoxygenase, and resulting in the generation of 15(R)-hydroxy-5,8,11,13-eicosatetraenoic acid (15(R)-HETE), i.e. with the opposite chirality to that produced in the lipoxygenase reaction. Now a new publication demonstrates that some PGD2, but not PGE2, is formed also - again with the 15(R)-configuration (Giménez-Bastida, J.A. et al. Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15R-prostaglandins that inhibit platelet aggregation. FASEB J., 33, 1033-1041 (2019); DOI). This may contribute to the therapeutic effects of aspirin.
Two weeks ago, I commented on the need for care in preparing the title of their publications, and this is also true for the abstracts. As I will not have access to the above publication for a year, I was grateful that it had an accurate title and abstract - certainly enough for my diletante requirements. In contrast this week, I came across a paper in my literature search that claimed in the title to have discovered a novel keto fatty acid in a plant source, but with no structural information whatsoever in the abstract.
February 13th 2019
The UK government recently announced that new funds (£30M) were being made available to universities for research into the discovery of new antibiotics, as pharmaceutical companies seem to believe that such research is not cost effective. I hope that some of this money will go to lipid biochemists, as bacterial lipopeptides are among our best hopes for success. Cyclic lipopeptides appear especially promising, and a new review discusses their biosynthesis by ribosomal and nonribosomal mechanisms as well as their therapeutic potential (Monaim, S.A.H.A. et al. Bacteria hunt bacteria through an intriguing cyclic peptide. Chemmedchem, 14, 24-51 (2019); DOI). Although to date cyclic lipopeptides have greater antibacterial potency and greater oral bioavailability, linear lipopeptides have significant activity and cannot be neglected in that they are more accessible by chemical synthesis, so that modified forms can easily be produced in quantity (Moon, S.H. and Huang, E. Novel linear lipopeptide paenipeptin C binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane. BMC Microbiol., 19, 6 (2019); DOI). The polymyxins have been around since the 1960s, but they were abandoned as systemic antibiotics because of nephrotoxicity. However, they have made something of a comeback as a drug of last resort against drug resistant Gram-negative bacterial strains, aided by the development of new derivatives. They have value also in that they damage the outer membranes of target bacteria and render them more permeable to other antibiotics (Vaara, M. Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics. Molecules, 24, 249 (2019); DOI).
It may seem surprising to some, but the essentiality of dietary α-linolenic acid (18:3(n-3)) was doubted by many in the lipid community until the 1970s, mainly it seems because it did not cure the dermal symptoms of EFA deficiency. The finding that docosahexaenoic acid (DHA) is necessary for optimum retinal function did not attract much attention, and the position only changed when it was observed that Greenland Eskimos had a low incidence of atherosclerotic coronary disease because of the anti-thrombotic effect of eicosapentaenoic acid in the diet. The rest as they say is history (Spector, A.A. and Kim, H.-Y. Emergence of omega-3 fatty acids in biomedical research. PLEFA, 140, 47-50 (2019); DOI). The authors suggest that we should take note of the delay in recognizing the importance of omega-3 fatty acids if we are to avoid similar pitfalls in future.
February 6th 2019
In my blog of January 16th, I commented briefly on the strange fact that a fatty acid present at rather low levels only in tissues, i.e. myristic or 14:0, had been adopted by natural selection almost exclusively for N-acylation of proteins. I suppose that it is advantageous to have a straight-chain saturated molecule for this purpose, as this may insert more easily into a membrane in comparison to say an unsaturated fatty acid with a kink in the 3-dimensional shape, but why 14:0? Now a new publication provides an explanation for how this occurs if not why (Soupene, E. and Kuypers, F.A. ACBD6 protein controls acyl chain availability and specificity of the N-myristoylation modification of proteins. J. Lipid Res., in press; DOI). It is demonstrated that a protein designated 'ACBD6' supports the reaction of N-myristoyl-transferase enzymes under unfavorable substrate-limiting conditions, and prevents utilization of potentially competing species such as 12:0 or 16:0.
I have the impression that authors do not put enough thought into the titles of their papers. There is an art to it and titles that avoid abbreviations/acronyms and are brief but to the point are my favourites, such as this recent review (Lone, M.A. et al. 1-Deoxysphingolipids. Biochim. Biophys. Acta, 1864, 512-521 (2019); DOI). The title of the paper is in fact shorter than the abbreviated name of the journal, but it tells us all we need to know. There are others who would produce a title such as "The chemistry, biochemistry and physical chemistry of 1-deoxysphingolipids with special reference to et cetera, et cetera". Whatever the title, they are fascinating lipids, not least because they have potent anti-cancer activity. You can find an introduction to the topic on this website herehttp://www.lipidhome.co.uk
I was sorry to learn of the death of Professor Rodolfo R. Brenner from Argentina, who died last year just before his 96th birthday. I first met him in the 1960s when he visited Ralph Holman's lab, where I was a post-doc, and this encounter lead to a collaborative project and eventually a joint publication. I remember him as an enthusiastic scientist who gave great encouragement to a young man at the start of his scientific career. There is a brief memorial in PLEFA.
Jan 30th 2019
There seems to be particular interest in the epoxyeicosatrienoic acids (EETs) at present because of their therapeutic potential, and a new study demonstrates that 11,12-EET enhances the process by which immature precursor cells develop into mature blood cells (hematopoiesis) and their further development (engraftment) in mice and zebrafish in vitro. For the first time, a receptor for EETs has been identified, i.e. GPR132 - a low-affinity EET receptor with physiological relevance in hematopoiesis (Lahvic, J.L. et al. Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132. Proc. Natl. Acad. Sci. USA, 115, 9252-9257 (2018); DOI).
The Journal of Biological Chemistry has just selected a paper that deals with EETs among other oxylipins as their paper of 2018 in their Lipids section (Moon, S.H. et al. Heart failure-induced activation of phospholipase iPLA2γ generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore. J. Biol. Chem., 293, 115-129 (2018); DOI). In brief, in non-failing human hearts, one isoform of phospholipase A (cPLA2ζ) channels arachidonic acid into protective EETs, whereas in failing hearts, opening of the mitochondrial permeability transition pore increases the activity of a second isoform of phospholipase A (cPLA2γ) that channels arachidonic acid into toxic HETEs. A second lipid biochemistry paper is their 2018 choice for the Immunology section.
Incidentally, for those interested in the history of lipid science, my mentor and colleague Frank Gunstone was the first to identify and characterize a naturally occurring epoxy fatty acid, i.e. vernolic acid or 12,13-epoxy-octadec-cis-9-enoic acid from the seed oil of Vernonia anthelmintica (Gunstone, F.D. Fatty acids. Part II. The nature of the oxygenated acid present in Vernonia anthelmintica (Willd.) seed oil. J. Chem. Soc., 1611-1616 (1954); DOI). He told me a few years ago that on thinking back, he was now especially pleased with this work because it was accomplished without the aid of chromatography, spectroscopic techniques or computers (any one remember tables of logarithms?). Rather, he had a balance, a burette and his knowledge of chemical reactions - see also his article in the Lipid Library for a general review of Fatty Acid Analysis before Chromatography. Frank recently celebrated his 96th birthday, but is frail and living in a retirement home. Happily, he has an extensive family nearby, including many greatgrandchildren, and he still has a zest for life.
Jan 23rd 2019
In recent years, I have read any number of reviews extolling the virtues of the various methodologies available for lipidomics, especially in relation to mass spectrometry, but I have rather enjoyed reading one which deals more with the limitations. In addition to MS (with and without chromatography), nuclear magnetic resonance is discussed, as well as universal detectors for HPLC (evaporative light-scattering and charged-aerosol detectors) (Khoury, S. et al. Quantification of lipids: model, reality, and compromise. Biomolecules, 8, 174 (2018); DOI - open access). With all of these, quantification is the main issue and the choice of internal standards is critical. While standards are available for most lipid classes, relatively few are available for specific molecular species. The authors point out that for example, 9856 species are listed in the LIPID MAPS® Lipidomics Gateway for glycerophospholipids but only about 80 analytical standards are available commercially. There may be differences in the response to species within a lipid class because of differences in fatty acid composition - hence the need for the 'compromise' of the title. Incidentally, I was pleased to see that there is still interest in universal detectors for HPLC, as I was under the impression that they were in danger of being forgotten.
While we should be aware of the limitations of mass spectrometry, we should also acknowledge its successes, and I have been impressed by a paper describing the separation and quantification of glucosyl- and galactosylceramides, which are virtually identical in structure, by differential ion mobility spectrometry (Xu, H.B. et al. DMS as an orthogonal separation to LC/ESI/MS/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid. J. Lipid Res., 60, 200-211 (2019); DOI).
January 16th 2019
A novel lipid to catch my eye this week is 1,28-octacosa-6,9,12,15-tetraenedioate or in other words a C28 dicarboxylic acid with four double bonds, probably produced in tissues by chain elongation of arachidonate, followed by ω-oxidation by various CYP450 enzymes (Wood, P.L. Endogenous anti-inflammatory very-long-chain dicarboxylic acids: potential chemopreventive lipids. Metabolites, 8, 76 (2018); DOI). Although much about its origin is a matter for conjecture, plasma levels are greatly reduced in certain cancers, so it obviously warrants further investigation. It would also be interesting to know whether similar very-long-chain oxylipins remain to be discovered, as few analysts look that far out in chromatograms.
I am always intrigued by how natural selection has picked certain fatty acids for particular purposes. For example, myristic acid is a rather minor fatty acid in all tissues and it has no functional groups in the chain to modify its three-dimensional shape, yet it is used almost exclusively for N-acylation of proteins. Another fatty acid with perhaps surprising properties is palmitoleic acid (9-16:1), which unusually is O-acylated, as opposed to S- or N-acylated, to a specific serine residue in the Wtn family of proteins and is essential for their vital functions in fetal development (see my web page on proteolipids). Such fatty acylation of Wnt is also required for its recognition by the co-chaperone 'Wntless' and for its binding to the 'Frizzled' receptor family. For background, I had to look this up in Wikipedia and found that "When activated, Frizzled leads to activation of Dishevelled in the cytosol" - some biochemists obviously have a sense of humour, although it sounds like me getting up in the morning. A new review describes the structures of these proteins and how the palmitoleate fits into a specific groove in the receptor to facilitate binding and thence signalling (Nile, A.H. and Hannoush, R.N. Fatty acid recognition in the Frizzled receptor family. J. Biol. Chem., 294, 726-736 (2019); DOI - Author's choice).
January 9th 2019
Gangliosides are fascinating lipids, not least because they demolish any definition of lipids based on their solubility in organic solvents. In the Folch extraction procedure, gangliosides partition into the aqueous phase. There is no doubt that the bargain of the week is a comprehensive review (more than 300 references) of the chemistry and metabolism of gangliosides (Sandhoff, R. and Sandhoff, K. Emerging concepts of ganglioside metabolism. FEBS Letts, 592, 3835-3864 (2018); DOI - open access). The article is dedicated to Professor Wilhelm Stoffel on the occasion of his 90th birthday. I have some work to do now to update my web page on this lipid class, especially as there is a further review article on glycosphingolipid-enriched lipid rafts in immune systems in the same journal issue (also open access).
The first new lipid that I have encountered in the new year is an unusual glycolipid surfactant of bacterial origin (Gauthier, C. et al. Structural determination of ananatoside A: An unprecedented 15-membered macrodilactone-containing glycolipid from Pantoea ananatis. Carbohydrate Res., 471, 13-18 (2019); DOI). It consists of glucose esterified to two 3-hydroxy fatty acids to form a novel cyclic structure.
For those fortunate enough to have access (not me), a new book is available - "Sphingolipids in Cancer" edited by Charles E. Chalfant and Paul B. Fisher (Advances in Cancer Research, Volume 140, Pages 1-388 (2018)), while a substantial review on lipid rafts has been published (Cebecauer, M. et al. Membrane lipid nanodomains. Chem. Rev., 118, 11259-11297 (2018); DOI).
Why do PDF files from journals vary so much in size? A 9-page pdf that I downloaded from one journal this week was 16Mb, while a 30-page pdf in another was only 2 Mb; the number and quality of the illustrations did not seem to be a factor. I have a fast broadband connection and more disk space than I am every likely to need, so it hardly matters to me, but what about our scientific colleagues around the world without such generous provision?
I am not sure if the word 'fatberg' has found its way into any modern dictionary, but their existence is certainly proving a concern to towns in the UK (see the BBC News website). This is one problem in lipid science/technology that I am happy to leave to others to solve.
January 2nd 2019
At this time of year, I have usually looked back through the reference lists in my literature survey pages to see which lipid classes have been trending in relation to my Lipid Essentials pages. This approach is not ideal in that a single review issue of a journal can distort the picture, but every year until now, sphingosine-1-phosphate and phosphoinositides have topped the list. Instead, this year I have used the log that I keep of the regular updates to my web pages in this section to determine where I have had to make most improvements. These can range from simply a new reference and/or a line of text to more substantial revisions (and hopefully on rare occasions only to correction of errors). The clear winner under my new approach was my web page on hydroxyeicosatetraenoic acids (HETE) closely followed by that on specialized pro-resolving mediators (SPMs). If the web page on leukotrienes is also taken into account, it is evident that oxylipin research is where I appear to be noticing appreciable progress. Among the glycerolipids, triacylglycerols (surprisingly?) and phosphoinositides tied for first place (although the latter wins when the web page on glycosylphosphatidylinositol anchors for proteins is taken into account), with the web page on phosphatidic acid (and lysoPA) a close third. Endocannabinoids were also well represented in my updates. Other than sphingosine-1-phosphate, my sphingolipid web pages tended to be updated relatively less frequently, as were those on fatty acids other than oxylipins. The poor relations were the web pages on cyanolipids (zero updates), and ceramide-1-phosphate and hopanoids (1 each).
The first special review issue of a journal of the new year is on the topic of "Brown and Beige Fat: From Molecules to Physiology" edited by Paul Cohen (Biochim. Biophys Acta, 1864, Issue 1, Pages 1-112 (January 2019)).
December 19th 2018
The concept of lipid rafts in membranes is an important one in that it governs many of the functions of sphingolipids in membranes. Although there are some dissenting voices, there appears to be a large area of agreement among experts in the field of their existence and relevance. I can recommend a new and relatively brief review as an introduction to the topic (Goñi, F.M. ‘Rafts'': A nickname for putative transient nanodomains. Chem. Phys. Lipids, 218, 34-39 (2019); DOI). Among a number of key conclusions, the author deplores the continued use of cold extraction with Triton X-100 as a standard procedure for raft isolation, as it is a source of artefacts. Also, the author obviously does not like the term 'rafts', and I sympathize in that it does appear trivial with little meaning from a scientific standpoint. Instead, he suggests the term '(transient) nanodomain'. While I agree with his idea in principle, his suggestion seems to me to be too general in that it could also apply to other membranes regions such as those enriched in polyunsaturated fatty acids, which may form when sphingolipids segregate. As sphingolipids are the defining constituents of rafts, can I suggest 'sphingoid nanodomains' as an alternative name?
Phytoprostanes and phytofurans are formed in plants via non-enzymatic, free radical-catalysed pathways similar to isoprostane synthesis in animals. They have similar molecular structures to animal oxylipins so may influence animal biology when they are absorbed from plant foods in the diet with potential benefits to human health. A new review summarizes the available evidence (Medina, S. et al. Structural/functional matches and divergences of phytoprostanes and phytofurans with bioactive human oxylipins. Antioxidants, 7, 165 (2018); DOI - open access).
I wish all my readers a happy Christmas and a prosperous lipidic New Year.
December 12th 2018
The membranes in photosynthetic cells are essential to all life on earth, so the more we understand them and their lipid components the better. The chloroplast inner and outer membranes and the thylakoid membranes within the chloroplast are obviously vital in this process, but the endoplasmic reticulum is also of great importance and mitochondria cannot be neglected. Monogalactosyldiacylglycerols with distinctive fatty acid compositions are key products, and they are essential for the integrity and function of the photosynthetic apparatus. Fatty acid synthesis and desaturation and synthesis of glyceride precursors occur in different parts of the cell so there is need for extensive lipid trafficking between membranes and organelles. A number of lipid transporters have now been identified, and there is evidence for lipid transport at contact sites between organelles. In addition, there is some evidence for vesicular transport. All of these are discussed in a new review on the topic (LaBrant, E. et al. Lipid transport required to make lipids of photosynthetic membranes. Photosynth. Res., 138, 345-360 (2018); DOI), which happily is open access.
Of course, the plasma membrane of plant cells is just as important as that in animals in that it protects the cell, regulates nutrient exchanges and acts as a platform to receive and send signals. Again, the lipid component are of central importance, but a major shift in our understanding of how the membrane functions has come with the recognition that sphingolipids, i.e. glycosyl inositol phosphoryl ceramides, are major constituents. Until recently, we knew little of them because they are relatively large, polar and complex molecules, which were easily overlooked with the available analytical methodology. The new era of lipidomics has shown that they are one of the most abundant constituents and has enabled comparisons to be drawn with the functions of gangliosides in animal membranes. For example, they are essential for the organization of the plasma membrane and they act as toxin receptors. Again, I am grateful for a new review for bringing me up to speed on the topic (Cassim, A.M. et al. Plant lipids: key players of plasma membrane organization and function. Prog. Lipid Res., 73, in press (2019); DOI).
December 5th 2018
In my early career at a Dairy Research Institute, we were concerned with the relative lack of essential fatty acids and excess of trans fatty acids in meat and dairy products because of microbial biohydrogenation in the rumen. I am not fully conversant with current research in this area but I guess that it continues. However, there does appear to be great interest in the byproducts of the reaction, i.e. conjugated linoleic and linolenic acids, from a quite different perspective. These have perceived benefits to human health, while the complex mixtures of isomers that are easily obtained from linoleate by chemical isomerization do not always have the same effects when administered in the diet. A number of linoleate isomerases have now been identified from bacteria, some of which occur as multi-enzyme systems. As many of the organisms occur in the human gut, they may affect human metabolism in vivo. A new review discusses the topic (Salsinha, A.S. et al. Microbial production of conjugated linoleic acid and conjugated linolenic acid relies on a multienzymatic system. Microbiol. Mol. Biol. Rev., 82, e00019 (2018); DOI).
New Scientist has just published a leader article with the provocative title "Time to break academic publishing's stranglehold on research". They comment on how little support there has been from funding agencies internationally for open access proposals. To quote further "The scientists who oppose it have real concerns, but are letting the perfect be the enemy of the good". I am sure that not all publishers are making 40% profits, as the leader suggests, but the big three (Elsevier, Springer, Wiley) are doing pretty well as subscription costs continue to rise. One unintended consequence of this is that academic libraries are no longer a place to browse for general information but have become much more specialized. For as long as I can remember, the libraries with which I have been associated have been faced each year with a necessity to cut the numbers of journal subscriptions as their budgets have been constrained. To compensate, we have greater access online to many journals from the big three publishers, but less to smaller publishers, including those linked to many academic societies (such as ACS, Biochemical Society, and University Presses). For example, my former Institute has just dropped its subscription to the Journal of Biological Chemistry as an economic measure in order to retain journals more in line with its limited remit. Is there also a "stranglehold on research", as the title of the leader suggests? You may be better qualified than I to answer. By the way, I would like to see more open access articles in New Scientist itself.
Older entries in this blog are archived by year as follows-
|Author: William W. Christie||Updated: April 17th, 2019||Credits/disclaimer|